Ziran Chinese Medicine - Seattle, Washington 98112

Ziran Chinese Medicine is categorized under Restaurants in Seattle, WA .

Business Name: Ziran Chinese Medicine
Contact Person: Toshi Nakajima, Principal
Address: 217 17th Avenue East Apartment 5, Seattle, Washington 98112
Phone Number: (206) 854-4376
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Restaurants
SIC Code: 5812
NAICS Code: 7225111
Share This Business:
Related Businesses: Plum Cafe - Seattle, WA 98112
Rover's - Seattle, WA 98112
Brunch & Lunch LLC - Seattle, WA 98112
Mc Gilvra's Bar & Restaurant - Seattle, WA 98112
Thomas Kimberly J - Seattle, WA 98112
Beach Seafood Bars - Seattle, WA 98112
Cafe Parco - Seattle, WA 98112
Madison Espresso & Yogurt - Seattle, WA 98112
Remedy Teas - Seattle, WA 98112
Montlake Ale House - Seattle, WA 98112
Canterbury-Aie & Eats - Seattle, WA 98112
Mcgilvra's - Seattle, WA 98112
Subway - Seattle, WA 98112
Teriyaki 2 Go - Seattle, WA 98112
Palermo - Seattle, WA 98112
Pig N Whistle - Seattle, WA 98112
Bistro & Bites - Seattle, WA 98112
Europa Bar And Restraunt - Seattle, WA 98112
The Family Kitchen - Seattle, WA 98112
Nicoloudakis Inc - Seattle, WA 98112

The company Ziran Chinese Medicine provides B2C services in the form of Restaurants from its single location in Washington. 1 to 4 employees work for Ziran Chinese Medicine, and the business now earns $500.000 to $999.999 per annum.

Ziran Chinese Medicine was launched in 0 and is classified under SIC code and category 5812 , and NAICS number and grouping 7225111 . To contact Ziran Chinese Medicine, please call Toshi Nakajima, Principal with the phone number (206) 854-4376 or visit its single location at 217 17th Avenue East Apartment 5 in Seattle, Washington 98112.

The location of the single location can also be found using the coordinates 47.619849,-122.310083. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.